ESR1 and neoplasm: Elevated expression levels of BMP6 and BMP7 have been associated with enhanced anti-tumor immune responses, as these ligands increase cytotoxic immune cell infiltration and augment their effector functions, correlating with improved clinical prognosis in ER-positive subtypes [70].